Design and characterization of transdermal films containing ketorolac tromethamine

International Journal of PharmTech Research

Volumn 3, Issue 1, 2011, Pages 449-458

  Fetih, G ^a   Ibrahim, M A ^b,c   Amin, M A ^b  

^a Assiut University   (Egypt)

^b Al Azhar University   (Egypt)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Adhesive; Ketorolac tromethamine; Penetration enhancers; Polymeric films; Transdermal delivery

Indexed keywords

CARBOXYMETHYLCELLULOSE; GLYCOCHOLATE SODIUM; KETOROLAC TROMETAMOL; OLEYL ALCOHOL; POLYMER; POVIDONE; PROPYLENE GLYCOL;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOFILM; DIFFUSION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG RELEASE; ENDURANCE; FILM; HAIRLESS RAT; HYDROPHILICITY; IN VITRO STUDY; NONHUMAN; PHYSICAL PARAMETERS; POLYMERIZATION; RAT; SKIN; SKIN PERMEABILITY; THICKNESS;

EID: 79951563343     PISSN: None     EISSN: 09744304     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Rooks W.H., Maloney P.J., Shott L.D., Schuller M.E., Sevelius H., Strosberg A.M., Tanenbaum L., Tomolonis A.J., Wallach M.B., Waterbury D., Yee J.P. The analgesic and anti-inflammatory profile of ketorolac and its tromethamine salt. Drugs Exp. Clin. Res., 1985, 11, 479-492.
2. Buckley M.M.T., Brogden R.N. Ketorolac: A review of its pharmacodynamic and pharmacokinetic properties. Drugs, 1990, 39, 86-90.
3. Tiwari S.B., Udupa N. Investigation into the potential of iontophoresis facilitated delivery of ketorolac. Int. J. Pharm., 2003, 260, 93-103.
4. Reinhart D.I. Minimizing the adverse effects of ketorolac. Drug Safety, 2000, 22, 487-497.
5. Roy S.D., Manoukian E.M., Combs D. Absorption of transdermally delivered ketorolac acid in humans. J. Pharm. Sci., 1995, 84, 49-52.
6. Roy S.D., Manoukian E. Transdermal delivery of ketorolac tromethamine: permeation enhancement, device design, and pharmacokinetics in healthy humans. J. Pharm. Sci., 1995, 84, 1190-1196.
7. Cho Y.A., Gwak H.S. Transdermal delivery of ketorolac tromethamine: effects of vehicles and penetration enhancers. Drug Dev. Ind. Pharmacy, 2004, 30, 557-564.
8. Khurana R., Ahuja A., Khar R.K. Development and evaluation of mucoadhesive films of miconazole nitrate. Indian J. Pharm. Sci., 2000, 62, 447-453.
9. Agarwal V., Mishra B. Design, development and biopharmaceutical properties of buccoadhesive compacts of pentazocine. Drug Dev. Ind. Pharm., 1999, 25, 701-709.
10. Okamoto H., Taguchi H., Iido K., Danjo K. Development of polymer film dosage forms of lidocaine for buccal administration. I. Penetration rate and release rate. J. Control. Release, 2001, 77, 253-260.
11. Padula C., Colombo G., Nicoli S., Catellani P.L., Massimo G., Santi, P. Bioadhesive film for the transdermal delivery of lidocaine: in vitro and in vivo behavior. J. Control. Release, 2003, 88, 277-285.
12. Nicoli S., Penna E., Padula C., Colombo P., Santi P. New transdermal bioadhesive film containing oxybutynin: in vitro permeation across rabbit ear skin. Int. J. Pharm., 2006, 325, 2-7.
13. Padula C., Nicoli S., Colombo P., Santi P. Single-layer transdermal film containing lidocaine: modulation of drug release. Eur. J. Pharmaceutics and Biopharmaceutics, 2007, 66, 422-428.
14. Patel V.M., Prajapati B.G., Patel M.M. Design and characterization of chitosan- ontaining mucoadhesive buccal patches of propranolol hydrochloride. Acta Pharm., 2007, 57, 61-72.
15. Korsmeyer R.W., Gurny R., Doelker E., Buri P., Peppas N.A. Mechanism of solute release from porous hydrophilic polymers. Int. J. Pharm., 1983, 15, 25-35.
16. Green P.G., Guy R.H., Hadgraft J. In vitro and in vivo enhancement of skin permeation with oleic and lauric acids. Int. J. Pharm., 1988, 48, 103-111.
17. Lee C., Uchida T., Kitagawa K., Yagi A., Kim N., Goto S. Relationship between lipophilicity and skin permeability of various drugs from an ethanol/water/lauric acid system. Biol. Pharm. Bull., 1994, 17, 1421-1424.
18. Smith S.W., Anderson B.D. Human skin permeability enhancement by lauric acid under equilibrium aqueous conditions. J. Pharm. Sci., 1995, 84, 551-556.
19. Nicoli S, Rimondi S., Colombo P., Santi P. Physical and chemical enhancement of transdermal delivery of triptorelin. Pharm. Res., 2001, 18, 1634-1637.
20. Artusi M., Nicoli S., Colombo P., Bettini R., Sacchi A., Santi P. Effect of chemical enhancers and iontophoresis on thiocolchicoside permeation across rabbit and human skin in vitro. J. Pharm. Sci., 2004, 93, 2431-2438.
21. Amnuaikit C., Ikeuchi I., Ogawara K., Higaki K., Kimura T. Skin permeation of propranolol from polymeric film containing terpene enhancers for transdermal use. Int. J. Pharm., 2005, 289, 167-178.
22. Barry B.W. Dermatological Formulations: Percutaneous Absorption. Marcel Dekker, New York and Basel, 1983, pp.154-173.
23. Polano M.K., Ponec M. Dependence of corticosteroid penetration on the vehicle. Arch. Dermatol., 1976, 112, 675-680.
24. Wotten P.K., Mollgaard B., Hadgraft J., Hoelgaard A. Vehicle effect on topical drug delivery. III. Effect of azone on the cutaneous permeation of metronidazole and propylene glycol. Int. J. Pharm., 1985, 24, 19-26.
25. Irwin W.J., Sanderson F.D., Li Wan Po A. Percutaneous absorption of ibuprofen: vehicle effects on transport through rat skin. Int. J. Pharm., 1990, 66, 193-200.
26. Fang J.-Y., Hwang T.-L., Leu Y.-L. Effect of enhancers and retarders on percutaneous absorption of flurbiprofen from hydrogels. Int. J. Pharm., 2003, 250, 313-325.
27. Barry B.W. Lipid-protein patitioning theory of skin penetration enhancement. J. Control. Release, 1991, 15, 237-248.
28. Higaki K., Amnuaikit C., Kimura T. Strategies for overcoming the stratum corneum; chemical and physical approaches. Am. J. Drug Deliv., 2003, 187-214,.
29. Ross J.S., Shah J.C. Reduction in skin permeation of N, N-diethyl-m-toluamide (DEET) by altering the skin/vehicle patition coefficient. J. Control. Release, 2000, 67, 211-221,.
30. Kim D.D., Chien Y.W. Transdermal delivery of dideoxynucleoside-type anti-HIV drugs. 2. The effect of vehicle and enhancer on skin permeation. J. Pharm. Sci., 1996, 85, 214-219.
31. Hoogstraate A.J., Senel S., Cullander C., Verhoe f J., Junginger H.E., Bodde H.E. Effects of bile salts on transport rates and routes of FTIC labeled compounds across porcine buccal epithelium in vitro. J Control Release, 1996, 40, 211-221.
32. Gandhi R., Robinson J.R. Mechanisms of penetration enhancement for transbuccal delivery of salicylic acid. Int. J. Pharm., 1992, 85, 129-140.
33. Veuillez F., Kalia Y.N., Jacques, Y., Deshusses J., Buri P. Factors and strategies for improving buccal absorption of peptides. Eur. J. Pharm. Biopharm., 2001, 51, 93-109.
34. Samrat M., Uday M. Chemistry and biology of bile acids. Curr. Sci., 2004, 87, 1666-1683.